9 unknown. 9 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Unknown 9 |
| Phase 2 | 4 | Unknown 4 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma ADRCs, Standard Care, Placebo - Scleroderma, Diffuse | Phase 3 | Unknown | Paracrine, INC. | 174 | 2023-02-28 | 2022-09-28 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis Pirfenidone, Placebo oral capsule, Steroids - Systemic Sclerosis | Phase 2 / Phase 3 | Unknown | RenJi Hospital | 72 | 2017-05-01 | 2017-03-01 |
| Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis Probiotic, Placebo - Systemic Sclerosis, Scleroderma | Phase 3 | Unknown | Federal University of São Paulo | 76 | 2014-12-01 | 2014-11-27 |
| Serial Night Time Position Splint on Systemic Sclerosis Serial night time position splint, Drug treatment - Diffuse Systemic Sclerosis | Phase 3 | Unknown | Federal University of São Paulo | 76 | 2010-01-01 | 2012-05-01 |
| Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms 0.9% nitroglycerin in TAM cream, vehicle cream - Raynaud Disease | Phase 3 | Unknown | MediQuest Therapeutics | 100 | 2009-06-01 | 2010-07-20 |
| A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon Nitroglycerin, Topical AmphiMatrix - Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma | Phase 3 | Unknown | MediQuest Therapeutics | 200 | 2007-12-01 | 2010-02-05 |
| Platelet Gel in Systemic Sclerosis Platelet Gel - Scleroderma, Systemic | Phase 2 / Phase 3 | Unknown | Università Politecnica delle Marche | 40 | 2007-03-01 | 2007-04-20 |
| High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis N-acetylcysteine (NAC) - Scleroderma, Diffuse | Phase 2 / Phase 3 | Unknown | Università Politecnica delle Marche | 45 | 2007-01-01 | 2007-01-30 |
Scleroderma, Diffuse (7) · Raynaud Disease (2) · Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Systemic Vasculitis (1) · Undifferentiated Connective Tissue Diseases (1)
Connective Tissue Diseases (9) · Skin Diseases (9) · Skin and Connective Tissue Diseases (9) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Embolism and Thrombosis (2) · Livedoid Vasculopathy (2) · Peripheral Vascular Diseases (2) · Skin Diseases, Vascular (2) · Thrombosis (2) · Arthritis (1) · Autoimmune Diseases (1) · Immune System Diseases (1) · Joint Diseases (1)
Nitroglycerin (2) · Acetylcysteine (1) · COVID-19 Vaccines (1) · Probiotics (1) · Standard of Care (1) · Steroids (1) · pirfenidone (1)
Federal University of São Paulo (2) · MediQuest Therapeutics (2) · Università Politecnica delle Marche (2) · Paracrine, INC. (1) · Paul R Fortin (1) · RenJi Hospital (1)
Brazil (2) · Italy (2) · United States (2) · Canada (1) · China (1)
Armando Gabrielli, MD, professor (1) · Armando Gabrielli, MD,professor (1) · Cristiane Kayser (1) · Jamil Natour, PhD (1) · Jan Ohrstrom, PhD (1) · Jeff Gregory, MD (1) · Paul R Fortin, MD,MPH,FRCPC (1)